Wednesday, October 7, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· July 15, 2026

Goldstorm Metals Commences Phase 1 Drill Program at the Crown Project, British Columbia

View original at finance.yahoo.com
Goldstorm Metals Commences Phase 1 Drill Program at the Crown Project, British Columbia Vancouver, British Columbia--(Newsfile Corp. - July 15, 2026) - Goldstorm Metals Corp…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Goldstorm plans to drill the Delta West Zone, located approximately 10 kilometres directly south of the Valley of the Kings Gold Deposit at the Brucejack Mine; Delta West was discovered by the Company's reconnaissance team during the 2025 field season.

    60% confidence
  • Reinterpretation of geophysical and geological datasets supports the 'Thrust Fault Model', suggesting thrust-associated mineral systems found at the Treaty Creek and KSM deposits may extend southward onto the Crown Property.

    60% confidence
  • A grab sample from a shear-hosted quartz vein containing fine-grained pyrite returned greater than 39 g/t gold, and follow-up prospecting identified numerous sub-parallel mineralized structures across a 500 m by 800 m gossanous area, with multiple samples returning significant gold values.

    60% confidence
  • Excitement at commencing the Company's first-ever drill program at the Crown Project.

    60% confidence
  • The widely spaced drill holes have been strategically designed to efficiently evaluate the strongest surface mineralization and coincident geophysical targets.

    60% confidence
  • The initial phase will consist of three HQ- and NQ2-size drill holes targeting the Copernicus and Orion Spine porphyry targets, drilled to depths of up to 800 metres to test the extent of the large IP chargeability anomalies.

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com